Search Within

Andrew D Seidman

  1. "GSK Faculty"
Formats
  1. Meeting Abstract (20)
  2. Journal Article (14)
Groups
  1. Breast Medicine Service (34)
  2. Department of Medicine (34)
  3. GSK Faculty (34)
  4. Solid Tumor Oncology Division (34)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (30)
  6. Epidemiology and Biostatistics (22)

More Groups

People
  1. Larry Norton (14)
  2. Shanu Modi (13)
  3. Adrienne Boire (11)
  4. Clifford Hudis (11)
  5. Jacqueline Bromberg (11)
  6. Chau Dang (10)

More People

Years
  1. 2024 (2)
  2. 2023 (1)
  3. 2022 (5)
  4. 2021 (2)
  5. 2020 (2)
  6. 2018 (1)

More Years

Publications
  1. Journal of Clinical Oncology (7)
  2. Cancer Research (6)
  3. International Journal of Radiation Oncology, Biology, Physics (6)
  4. Neuro-Oncology (5)
  5. Clinical Breast Cancer (2)
  6. Clinical Cancer Research (2)

More Publications

Publishers
  1. American Association for Cancer Research (8)
  2. Elsevier Inc. (8)
  3. American Society of Clinical Oncology (7)
  4. Oxford University Press (6)
  5. Nature Publishing Group (2)
  6. Elsevier Science, Inc. (1)

More Publishers

Results (34)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical evidence for drug penetration of capecitabine and lapatinib uptake in resected brain metastases from women with metastatic breast cancer
    Meeting Abstract

    Morikawa, A.; Peereboom, D. M.; Smith, Q. R.; Thorsheim, H.; Lockman, P. R.; Simmons, A. J.; Weil, R. J.; Tabar, V.; Steeg, P. S.; Seidman, A. D.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • An exploratory analysis of the role of dasatinib in preventing progression of disease in bone in patients with metastatic breast cancer
    Meeting Abstract

    Cadoo, K. A.; Morris, P. G.; Lake, D. E.; D'Andrea, G. M.; Dickler, M. N.; Gilewski, T. A.; Dang, C. T.; McArthur, H. L.; Bromberg, J. F.; Goldfarb, S. B.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Prognostic implications of receptor status and extracranial disease in patients with breast cancer brain metastases treated with stereotactic radiosurgery
    Meeting Abstract

    Yang, T.; Oh, J.; Folkert, M.; Morikawa, A.; Seidman, A. D.; Yamada, Y.; Chan, T. A.; Beal, K.
    International Journal of Radiation Oncology, Biology, Physics (2013)

    Fulltext@MSK | Save
  • Tolerability and efficacy of targeting both mTOR and HER2 signaling in trastuzumab-refractory HER2+ metastatic breast cancer
    Meeting Abstract

    Gajria, D.; King, T.; Pannu, H.; Sakr, R.; Modi, S.; Drullinsky, P.; Syldor, A.; Patil, S.; Seidman, A.; Norton, L.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Capecitabine entry into brain metastases in women with breast cancer
    Meeting Abstract

    Peereboom, D. M.; Seidman, A. D.; Tabar, V.; Weil, R. J.; Thorsheim, H. R.; Smith, Q. R.; Lockman, P. R.; Steeg, P. S.
    Neuro-Oncology (2012)

    Fulltext@MSK | Save
  • Combined inhibition of mTORC1 with temsirolimus and HER2 with neratinib: A phase I study in patients with metastatic HER2-amplified breast cancer
    Meeting Abstract

    Gajria, D.; King, T. A.; Pannu, H.; Sakr, R.; Seidman, A. D.; Syldor, A.; Patil, S.; Maybody, M.; Norton, L.; Rosen, N.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Combined inhibition of mTORC1 with temsirolimus and HER2 with neratinib: A phase I/II study in patients with metastatic HER2-amplified or triple-negative breast cancer
    Meeting Abstract

    Gajria, D.; King, T.; Pannu, H.; Sakr, R.; Seidman, A. D.; Modi, S.; Dickler, M.; Drullinsky, P.; Syldor, A.; Sujata, P.; more...
    Cancer Research (2011)

    Fulltext@MSK | Save
  • A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer
    Journal Article

    Fornier, M. N.; Morris, P. G.; Abbruzzi, A.; D'Andrea, G.; Gilewski, T.; Bromberg, J.; Dang, C.; Dickler, M.; Modi, S.; Seidman, A. D.; more...
    Annals of Oncology (2011)

    Fulltext@MSK | Save
  • A phase I-II trial of dasatinib (D) in combination with weekly (w) paclitaxel (P) for patients (Pts) with metastatic breast carcinoma (MBC)
    Meeting Abstract

    Morris, P. G.; Abbruzzi, A.; D'Andrea, G.; Gilewski, T.; Lake, D.; Bromberg, J.; Dang, C.; Dickler, M.; Modi, S.; Seidman, A. D.; more...
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by weekly paclitaxel (P) with trastuzumab (T) and lapatinib (L) in HER2/neu-positive breast cancer is not feasible due to excessive diarrhea: Updated results
    Meeting Abstract

    Dang, C.; Lin, N.; Moy, B.; Come, S.; Lake, D.; Theodoulou, M.; Troso-Sandoval, T.; Dickler, M.; Gorsky, M.; D'Andrea, G.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save